← Back to Search

Velacur by Sonic Incytes for Portal Hypertension

N/A
Waitlist Available
Led By Samer Gawrieh, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one day
Awards & highlights

Study Summary

This trial looks at the relationship between a measure of liver stiffness and symptoms of portal hypertension in patients with advanced chronic liver disease.

Eligible Conditions
  • Portal Hypertension
  • Chronic Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one day
This trial's timeline: 3 weeks for screening, Varies for treatment, and one day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Liver Stiffness Measurements for Participants With Compensated Advanced Chronic Liver Disease With and Without Esophageal Varices Upon Esophagogastroduodenoscopy (EGD)
Platelet Count for Participants With Compensated Advanced Chronic Liver Disease
Other outcome measures
Correlation of Velacur Measurements to Non-Invasive Blood Markers for Predicting Advanced Fibrosis

Trial Design

1Treatment groups
Experimental Treatment
Group I: Velacur by Sonic IncytesExperimental Treatment1 Intervention
Patients with compensated advanced chronic liver disease (cACLD) who have not undergone liver transplantation will be scanned with Velacur.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Velacur
2021
N/A
~70

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,091 Total Patients Enrolled
Sonic IncytesIndustry Sponsor
5 Previous Clinical Trials
640 Total Patients Enrolled
Samer Gawrieh, MD4.67 ReviewsPrincipal Investigator - Indiana University
Indiana University Health, North Hospital, Indiana University Health, University Hospital
Medical School - University of Aleppo Faculty of Medicine, Doctor of Medicine
John H. Stroger, Jr. Hospital of Cook County, Residency in Internal Medicine
2 Previous Clinical Trials
436 Total Patients Enrolled
5Patient Review
My doctor is very knowledgeable and skilled in his area of expertise, gastroenterology and hepatology.

Media Library

Velacur by Sonic Incytes Clinical Trial Eligibility Overview. Trial Name: NCT04576897 — N/A
Portal Hypertension Research Study Groups: Velacur by Sonic Incytes
Portal Hypertension Clinical Trial 2023: Velacur by Sonic Incytes Highlights & Side Effects. Trial Name: NCT04576897 — N/A
Velacur by Sonic Incytes 2023 Treatment Timeline for Medical Study. Trial Name: NCT04576897 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still room for recruitment in this clinical research?

"Affirmative. Clinicaltrials.gov reveals that this medical research is presently recruiting participants, after being posted on February 1st 2021 and most recently updated January 25th 2022. The study requires the recruitment of 100 patients from a single location."

Answered by AI

What is the extant of enrollment for this experiment?

"Affirmative. The information available on clinicaltrials.gov verifies that this investigation is actively seeking participants, having being first announced on February 1st 2021 and recently updated on January 25th 2022. A total of 100 individuals are sought after from a single medical site."

Answered by AI
~17 spots leftby Apr 2025